Lundbeck
HLUN-B.CO
#2670
Rank
C$8.97 B
Marketcap
C$9.04
Share price
-1.12%
Change (1 day)
37.20%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): C$0.85

According to Lundbeck's latest financial reports the company's current EPS (TTM) is C$0.83. an increase over its 2024 EPS that were of C$0.60.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025C$0.6914.5%
2024C$0.6029.29%
2023C$0.4623.09%
2022C$0.3837.26%
2021C$0.28-84.61%
2020C$1.79-24.61%
2019C$2.37-42.06%
2018C$4.0940.7%
2017C$2.91146.26%
2016C$1.18-120.48%
2015C-$5.773231.32%
2014C-$0.17-115.78%
2013C$1.10-23.36%
2012C$1.43-48.01%
2011C$2.75-9.68%
2010C$3.0513.72%
2009C$2.6824.32%
2008C$2.16-6.05%
2007C$2.3081.77%
2006C$1.26-16.76%
2005C$1.52-17.58%
2004C$1.84